Stevens-Johnson syndrome induced by sodium valproate monotherapy

dc.contributor.author	Kikkeri, Naveen Narayanashetty
dc.contributor.author	Arunkumar, J. S.
dc.contributor.author	Keloji, Hanumanthayya
dc.contributor.author	Pai, Varadraj V.
dc.date.accessioned	2012-12-29T08:45:03Z
dc.date.available	2012-12-29T08:45:03Z
dc.date.issued	2012-01
dc.identifier.citation	International Journal of Critical Illness and Injury Science. 2012 Jan-Apr; 2(1): 44-45.	en_US
dc.identifier.issn	2229-5151
dc.identifier.uri	http://hdl.handle.net/123456789/304
dc.description.abstract	A case of Stevens-Johnson syndrome following treatment with sodium valproate is presented here. A 20-year-old male was put on sodium valproate monotherapy for the migraine, with generalized epilepsy. He developed vesicles and bullae in the oral and nasal mucosa with conjunctivitis, after 10 days of treatment. The lesions resolved after treating with systemic steroids. This case has been presented because Stevens-Johnson syndrome with sodium valproate monotherapy has been very rarely reported.	en_US
dc.language.iso	en	en_US
dc.publisher	Wolters Kluwer - Medknow	en_US
dc.subject	Steven-Johnson syndrome	en_US
dc.subject	Sodium valproate monotherapy	en_US
dc.title	Stevens-Johnson syndrome induced by sodium valproate monotherapy	en_US
dc.type	Article	en_US